Stock Events

Stock Events

Solana 

€1.78
51
+€0.08+4.71% Monday 06:02

Statistics

Day High
1.78
Day Low
1.78
52W High
36.23
52W Low
0.29
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Next
-0.29
0.04
0.38
0.71
Expected EPS
-0.29015260000000004
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 26H1.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap3.35B
LivaNova operates in the neuromodulation space, providing therapies for neurological disorders, which puts them in direct competition with Helius Medical Technologies.
Novartis
NVS
Mkt Cap279.67B
Novartis is a large pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, competing on a larger scale with Helius's niche market.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie has a strong presence in neuroscience, including R&D in neuromodulation, making it a competitor by offering alternative treatments for similar conditions.
Medtronic
MDT
Mkt Cap102.71B
Medtronic offers a wide range of neuromodulation devices, directly competing with Helius in providing medical technologies for neurological disorders.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb, with its extensive portfolio in neuroscience, competes in developing treatments for conditions that Helius also aims to address with its technology.

About

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
Show more...
CEO
Mr. Dane Carl Andreeff
Employees
19
Country
Canada
ISIN
US42328V8761

Listings

MU
DE
26H1.MU
STU
DE
26H1.STU
MX
MX
HSDT.MX
F
DE
26H1.F

0 Comments

Share your thoughts

FAQ

What is Solana stock price today?▼
The current price of 26H1.MU is €1.78 EUR — it has increased by +4.71% in the past 24 hours. Watch Solana stock price performance more closely on the chart.
What is Solana stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Solana stocks are traded under the ticker 26H1.MU.
Is Solana stock price growing?▼
26H1.MU stock has risen by +0% compared to the previous week, the month change is a +17.11% rise, over the last year Solana has showed a -99.09% decrease.
When is the next Solana earnings date?▼
Solana is going to release the next earnings report on May 07, 2026.
How many employees does Solana have?▼
As of May 06, 2026, the company has 19 employees.
In which sector is Solana located?▼
Solana operates in the Health & Wellness sector.
When did Solana complete a stock split?▼
The last stock split for Solana was on May 02, 2025 with a ratio of 1:15.
Where is Solana headquartered?▼
Solana is headquartered in Newtown, Canada.